Your browser doesn't support javascript.
loading
Quantitative proteomic analysis of anticancer drug RH1 resistance in liver carcinoma.
Ger, Marija; Kaupinis, Algirdas; Nemeikaite-Ceniene, Ausra; Sarlauskas, Jonas; Cicenas, Jonas; Cenas, Narimantas; Valius, Mindaugas.
Afiliação
  • Ger M; Vilnius University Institute of Biochemistry, Vilnius, Lithuania. Electronic address: marija.ger@bchi.vu.lt.
  • Kaupinis A; Vilnius University Institute of Biochemistry, Vilnius, Lithuania. Electronic address: algirdas.kaupinis@gf.vu.lt.
  • Nemeikaite-Ceniene A; State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania. Electronic address: a.ceniene@imcentras.lt.
  • Sarlauskas J; Vilnius University Institute of Biochemistry, Vilnius, Lithuania. Electronic address: jonas.sarlauskas@bchi.vu.lt.
  • Cicenas J; Vilnius University Institute of Biochemistry, Vilnius, Lithuania; Swiss Institute of Bioinformatics, Geneva, Switzerland; MAP Kinase Resource, Bern, Switzerland. Electronic address: j.cicenas@mapkinases.eu.
  • Cenas N; Vilnius University Institute of Biochemistry, Vilnius, Lithuania. Electronic address: narimantas.cenas@bchi.vu.lt.
  • Valius M; Vilnius University Institute of Biochemistry, Vilnius, Lithuania. Electronic address: mindaugas.valius@bchi.vu.lt.
Biochim Biophys Acta ; 1864(2): 219-32, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26596252

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aziridinas / Benzoquinonas / Carcinoma Hepatocelular / Neoplasias Hepáticas / Proteínas de Neoplasias Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aziridinas / Benzoquinonas / Carcinoma Hepatocelular / Neoplasias Hepáticas / Proteínas de Neoplasias Idioma: En Ano de publicação: 2016 Tipo de documento: Article